These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5900011)

  • 21. [Experience with the use of high intravenous doses of a coronary-active drug in the treatment of acute and chronic coronary insufficiency].
    Cinelli P; Grazzini M
    Minerva Cardioangiol; 1969 May; 17(5):317-23. PubMed ID: 5814987
    [No Abstract]   [Full Text] [Related]  

  • 22. [APROPOS OF THE USE OF A CORONARY VASODILATOR, RO 4-6486].
    AUDIER M; ARNOUX E; LUCCIONI AR; BORY M; POGGI L
    Arch Med Gen Trop; 1965; 42():159-60. PubMed ID: 14337401
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of benzodiazepine tranquilizers on the ischemic focus and redistribution of blood flow in the ischemic myocardium].
    Chichkanov GG; Bogolepov AK; Matsievskiĭ DD
    Biull Eksp Biol Med; 1984 Apr; 97(4):429-31. PubMed ID: 6722303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combined treatment of chronic coronary disease with pentaerythritol tetranitrate and propranolol].
    Florkiewicz H; Rymar B; Markiewicz M; Trojnar R; Rumiński W
    Pol Tyg Lek; 1981 Apr; 36(14):501-3. PubMed ID: 7267422
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of coronary insufficiency. Comparative study on the effect of a nitro compound (isosorbidedinitrate), a beta sympatholytic (bupranolol) and a drug combination (oxycardin)].
    Philipp R; Kutscha W
    Med Welt; 1980 May; 31(21):817-20. PubMed ID: 7392937
    [No Abstract]   [Full Text] [Related]  

  • 26. A study of a recognized antipsychotic agent as a tranquilizer in general practice.
    Donald JF
    Practitioner; 1969 Nov; 203(217):684-7. PubMed ID: 4904424
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical study of 1035 M.D. in the treatment of chronic coronary insufficiency. 40 cases].
    Warembourg H; Jaillard J
    Lille Med; 1968 Oct; ():Suppl 6:800-3. PubMed ID: 5748097
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of chlorazicin in combination with syncoumar on certain factors of the blood coagulation and anticoagulation systems in patients with chronic coronary insufficiency].
    Feniuk EV
    Ter Arkh; 1967 Oct; 39(10):48-50. PubMed ID: 5611717
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of the PETN-piridoxylate combination in the long-term treatment of cardiac failure in the aged patient].
    Rumeau M; Pourrat J; Chambeu Y
    Sem Hop; 1983 May; 59(19):1475-8. PubMed ID: 6310765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical trial of Cardiocap in coronary insufficiency].
    Baronti G; Del Corso P; Romboli L
    Minerva Cardioangiol; 1974 May; 22(5):344-55. PubMed ID: 4619188
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical and electrocardiographic study of myocardiosclerosis after treatment with vitamins B1 and B6].
    Rossi C; Vergallo L
    Minerva Cardioangiol; 1969 Oct; 17(10):768-72. PubMed ID: 5404968
    [No Abstract]   [Full Text] [Related]  

  • 32. [Controlled clinical study of large doses of etaphenone in coronary insufficiency].
    Del Guerico R
    Clin Ter; 1975 Aug; 74(4):337-63. PubMed ID: 1227752
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the objective evaluation of the effects of coronary vasoactive drugs].
    Lenti G; Cherchi A; Raffo M; Porrazzo G
    Minerva Med; 1966 Feb; 57(12):455-9. PubMed ID: 5910815
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapeutic effects of a new antispastic and anxiolytic preparation on various diseases of the digestive tract].
    Surrenti C
    Clin Ter; 1970 May; 53(3):235-46. PubMed ID: 5456481
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical evaluation of molsidomin in ischemic cardiopathy].
    Di Giacomo G; Nicolella U; Puligheddu M; Tripodi A; D'Ascoli C; Di Virgilio D
    Clin Ter; 1984 Oct; 111(2):141-6. PubMed ID: 6239736
    [No Abstract]   [Full Text] [Related]  

  • 36. [Beta-blocking drugs in coronary insufficiency. Clinical experiences with iproveratril].
    Guadagno L; Giannelli G; Ghiara F; Guadagno P; Zucchelli GP
    Minerva Med; 1967 Sep; 58(77):3288-94. PubMed ID: 6054782
    [No Abstract]   [Full Text] [Related]  

  • 37. A double blind comparative study of mianserin and a fixed combination of amitriptyline plus chlordiazepoxide.
    Dimitriou EC; Logothetis JA; Paschalidou M
    Adv Biochem Psychopharmacol; 1982; 32():213-22. PubMed ID: 7046365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recent contribution to the study on the effects of hexobendine in the treatment of coronary insufficiency].
    Diene G; Nigro P; Cottini E; Andreozzi GM; Mossuti E; Sorrentino F
    Boll Soc Ital Cardiol; 1973; 18(12):1213-21. PubMed ID: 4619973
    [No Abstract]   [Full Text] [Related]  

  • 39. [Fendiline hydrochloride as a therapeutic agent in chronic coronary insufficiency].
    Vichi FL
    Arq Bras Cardiol; 1980 Apr; 34(4):327-30. PubMed ID: 7002122
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatic rupture from anticoagulant therapy.
    Roberts MH; Johnston FR
    Arch Surg; 1975 Sep; 110(9):1152. PubMed ID: 808198
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.